glp 1 winner Amanda Bonello interviews Sabina Hemmi, founder of Winner, about the Safe Drugs Act and state bills threatening compounded GLP-1 access, including semaglutide and tirzepatide, and what patients can do to protect GLP-1 Weight Loss Medication -
Description
Pectin and complications after gastric surgery: normalisation of postprandial glucose and endocrine responses
Because GLP-1 therapies improve insulin regulation systemically, they may also enhance signaling pathways in the central nervous system
Multiple formulations
Research done as part of the drug's approval process for treating type 2 diabetes found people lost as much as 21 pounds over 10 months
This could be great news for non-alcoholic beverage brands
Uncertainty About Ongoing Access: If FDA removes tirzepatide from shortage list, compounding may become restricted
